Dendritic Cell Therapy in Composite Tissue Allotransplantation

A. W. Thomson, J. M. Sacks, Y. R. Kuo, R. Ikeguchi, E. K. Horibe, J. Unadkat, M. G. Solari, M. Feili-Hariri, W. P.A. Lee

Research output: Contribution to journalArticle

Abstract

Dendritic cells (DCs) are bone marrow-derived, professional antigen-presenting cells, with inherent tolerogenic function. The ability of immature or maturation-resistant DCs to regulate alloantigen-specific T-cell responses and to promote tolerance induction has been well demonstrated in organ and bone marrow transplantation. Recent data suggest that DCs can also promote long-term survival of composite tissue allografts in the absence of continued immunosuppressive drug therapy.

Original languageEnglish (US)
Pages (from-to)537-538
Number of pages2
JournalTransplantation proceedings
Volume41
Issue number2
DOIs
StatePublished - Mar 1 2009

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Fingerprint Dive into the research topics of 'Dendritic Cell Therapy in Composite Tissue Allotransplantation'. Together they form a unique fingerprint.

  • Cite this

    Thomson, A. W., Sacks, J. M., Kuo, Y. R., Ikeguchi, R., Horibe, E. K., Unadkat, J., Solari, M. G., Feili-Hariri, M., & Lee, W. P. A. (2009). Dendritic Cell Therapy in Composite Tissue Allotransplantation. Transplantation proceedings, 41(2), 537-538. https://doi.org/10.1016/j.transproceed.2009.01.011